885280-04-6 Usage
Uses
Used in Pharmaceutical Industry:
6-FLUORO-1H-BENZOIMIDAZOLE-2-CARBOXYLIC ACID METHYL ESTER is utilized as an intermediate in the production of various pharmaceuticals, specifically for the development of antiviral and antifungal drugs. Its unique fluorinated structure contributes to the enhancement of the pharmacological properties of these medications, improving their efficacy and selectivity.
Used in Agrochemical Industry:
In the agrochemical sector, 6-FLUORO-1H-BENZOIMIDAZOLE-2-CARBOXYLIC ACID METHYL ESTER is employed as a key intermediate in the synthesis of compounds that possess pesticidal properties, thereby playing a crucial role in crop protection and management.
Used in Heterocyclic Compounds Synthesis:
6-FLUORO-1H-BENZOIMIDAZOLE-2-CARBOXYLIC ACID METHYL ESTER is also used as an intermediate in the synthesis of a variety of heterocyclic compounds, which are known for their wide range of biological activities and applications in medicinal chemistry.
Used in Biologically Active Molecules Synthesis:
6-FLUORO-1H-BENZOIMIDAZOLE-2-CARBOXYLIC ACID METHYL ESTER is further utilized in the development of biologically active molecules, which have potential applications in various therapeutic areas, underlining its importance in the discovery and creation of novel pharmaceutical agents.
Check Digit Verification of cas no
The CAS Registry Mumber 885280-04-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,8 and 0 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 885280-04:
(8*8)+(7*8)+(6*5)+(5*2)+(4*8)+(3*0)+(2*0)+(1*4)=196
196 % 10 = 6
So 885280-04-6 is a valid CAS Registry Number.
885280-04-6Relevant articles and documents
NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS
-
Page/Page column 138, (2011/12/02)
Unsaturated nitrogen heterocyclic compounds of formula (I): (I), as defined in the specification, compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, Huntington's Disease, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
